Your browser doesn't support javascript.
loading
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.
Heitz, F; Harter, P; Åvall-Lundqvist, E; Reuss, A; Pautier, P; Cormio, G; Colombo, N; Reinthaller, A; Vergote, I; Poveda, A; Ottevanger, P B; Hanker, L C; Leminen, A; Alexandre, J; Canzler, U; Sehouli, J; Herrstedt, J; Fiane, B; Merger, M; du Bois, A.
Afiliación
  • Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Germany; Department for Gynecology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health. Electronic
  • Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Germany.
  • Åvall-Lundqvist E; Linköping University and Karolinska Institute, Linköping, Sweden.
  • Reuss A; Coordinating Center for Clinical Trials, Marburg, Germany.
  • Pautier P; Institut Gustave Roussy, Villejuif, France.
  • Cormio G; University of Bari and Gynecologic Oncology Unit, National Cancer Institute "Giovanni Paolo II", Bari, Italy.
  • Colombo N; University of Milano-Bicocca and Instituto Europeo di Oncologia, Milan, Italy.
  • Reinthaller A; Department of General Gynecology and Gynecologic Oncology, Gynecologic Cancer Unit - Comprehensive Cancer Center, Medical University of Vienna, Austria.
  • Vergote I; University of Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Poveda A; Instituto Valenciano de Oncología, Valencia, Spain.
  • Ottevanger PB; Radboud University Medical Center, Nijmegen, Netherlands.
  • Hanker LC; University of Schleswig-Holstein, Lübeck, Germany.
  • Leminen A; Women's Hospital, Haartmaninkatu 2, Helsinki, Finland.
  • Alexandre J; Hôpitaux Universitaires Paris Centre, Hôpital Cochin, Services de Cancérologie et d'Oncologie Gynécologique, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
  • Canzler U; Department of Gynecology and Obstetrics, TU Dresden, Dresden, Germany.
  • Sehouli J; Charité Campus Virchow-Klinikum, Berlin, Germany.
  • Herrstedt J; Odense University Hospital, Odense and Zealand University Hospital Roskilde, Denmark.
  • Fiane B; Department of Gynecology and Gynecologic Oncology, Stavanger University Hospital, Stavanger, Norway.
  • Merger M; Clinical Research, Boehringer Ingelheim Pharma, Biberach An der Riss, Germany.
  • du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Germany.
Gynecol Oncol ; 152(2): 235-242, 2019 02.
Article en En | MEDLINE | ID: mdl-30466805
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article